Active ingredientFidaxomicinCat. No. P-F043-001CAS 873857-62-6Family · Pharmaceutical analytical standards
Fidaxomicin
A narrow-spectrum macrocyclic antibiotic, barely absorbed from the gut, where it acts locally: approved in 2011 in the United States and Europe for Clostridioides difficile infections. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It was discovered twice: in 1975 in Italy as lipiarmycin, produced by Actinoplanes deccanensis, and in the 1980s in the United States as tiacumicin B; only later was it realised they were the same molecule.
Go to the active ingredient →Active ingredientFidaxomicinCat. No. P-F043-001CAS 873857-62-6
MetaboliteFidaxomicin Metabolite OP-1118Cat. No. P-F043-002CAS 1030825-28-5
Isotopically labelledFidaxomicin-d7Cat. No. P-F043-004CAS 2143934-06-7
ImpurityClostomicin ACat. No. P-F043-005CAS 106008-69-9
ImpurityDi-Methylated FidaxomicinCat. No. P-F043-006CAS 185248-68-4
ImpurityFidaxomicin Impurity 1Cat. No. P-F043-011
ImpurityFidaxomicin Impurity 2Cat. No. P-F043-012
ImpurityFidaxomicin Impurity 3Cat. No. P-F043-014
ImpurityFidaxomicin Impurity ACat. No. P-F043-015CAS 112396-61-9
ImpurityFidaxomicin Impurity BCat. No. P-F043-016
ImpurityMono-Methylated FidaxomicinCat. No. P-F043-019CAS 2987177-46-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.